MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.

MicroRNAs may function to promote or suppress tumor development, depending on the cellular context. The important role of microRNAs in regulating molecular pathways underlying tumorigenesis has been emphasized in hepatocellular carcinoma (HCC). MicroRNAs regulate gene expression via post-transcriptional mechanisms by inhibiting translation or by degrading mRNA. In this study, we show that microRNA-1 (miR-1) and microRNA-499 (miR-499) are capable of repressing the expression of the ets1 proto-oncogene, which plays a fundamental role in the extracellular matrix (ECM) degradation, a process required for tumor cell invasion and migration. We used luciferase reporter assays to demonstrate that miR-1 and miR-499 target the 3' untranslated region (UTR) of ets1. Overexpression of miR-1 and miR-499 in HepG2 cells led to downregulation of ets1 mRNA and protein as assessed by quantitative reverse transcription PCR and western blot analysis. Furthermore, overexpression of miR-1 and miR-499 inhibited the invasion and migration of HepG2 cells in matrigel invasion and transwell migration assays, respectively. These results suggest that miR-1 and miR-499 may play an important role in the pathogenesis of HCC by regulating ets1.

[1]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[2]  M. Nakashima,et al.  Ets-1 upregulates matrix metalloproteinase-1 expression through extracellular matrix adhesion in vascular endothelial cells. , 2002, Biochemical and biophysical research communications.

[3]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[4]  Y. Okada,et al.  Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors. , 1999, Journal of neuropathology and experimental neurology.

[5]  Y. Jiang,et al.  Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. , 2001, Biochemical and biophysical research communications.

[6]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[7]  V. Sementchenko,et al.  Ets target genes: past, present and future , 2000, Oncogene.

[8]  B. Vandenbunder,et al.  Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway , 2002, Oncogene.

[9]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[10]  T. Nakayama,et al.  Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma. , 2002, Hepato-gastroenterology.

[11]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[12]  A. Wellmann,et al.  The Ets‐1 transcription factor is up‐regulated together with MMP 1 and MMP 9 in the stroma of pre‐invasive breast cancer , 2001, The Journal of pathology.

[13]  I. Takanami,et al.  Expression of Ets-1 Is Correlated with Urokinase-Type Plasminogen Activator and Poor Prognosis in Pulmonary Adenocarcinoma , 2001, Tumor Biology.

[14]  Cui Jun The Construction of miRNA Expression Library for Human , 2007 .

[15]  Tara L. Kieffer,et al.  Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .

[16]  S. Friedman,et al.  Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling. , 2006, Seminars in liver disease.

[17]  S. Thorgeirsson,et al.  Comparative and integrative functional genomics of HCC , 2006, Oncogene.

[18]  T. Golub,et al.  Impaired microRNA processing enhances cellular transformation and tumorigenesis , 2007, Nature Genetics.

[19]  B. Vandenbunder,et al.  Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway , 2002, Oncogene.

[20]  M. Abe,et al.  ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 , 1999, Journal of cellular physiology.

[21]  S. Nakamura,et al.  Immunohistochemical expression of Ets‐1 transcription factor and the urokinase‐type plasminogen activator is correlated with the malignant and invasive potential in meningiomas , 2000, Cancer.

[22]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Creighton,et al.  Widespread deregulation of microRNA expression in human prostate cancer , 2008, Oncogene.

[24]  Zheng Wang,et al.  Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. Yamashita,et al.  Overexpression of Ets-1 transcription factor in angiosarcoma of the skin. , 2000, Pathology, Research and Practice.

[26]  K. Tanaka,et al.  Signal transduction and transcriptional regulation of angiogenesis. , 2000, Advances in experimental medicine and biology.

[27]  A. Wellmann,et al.  Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. , 2001, International journal of molecular medicine.

[28]  C. Sweep,et al.  Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer , 2002, Oncogene.

[29]  Krista A. Zanetti,et al.  Identification of metastasis‐related microRNAs in hepatocellular carcinoma , 2008, Hepatology.

[30]  Andrea Ventura,et al.  MicroRNAs and Cancer: Short RNAs Go a Long Way , 2009, Cell.

[31]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[32]  L. Gravitz Liver cancer , 2014, Nature.

[33]  P. Comoglio,et al.  Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. , 1997, Cytokine & growth factor reviews.

[34]  V. Mazzaferro,et al.  Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.

[35]  Laura Pelletier,et al.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.

[36]  X. Chen,et al.  Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. , 2010, Cancer research.